Filing Details

Accession Number:
0000899243-17-018552
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-07-19 16:06:38
Reporting Period:
2017-07-17
Filing Date:
2017-07-19
Accepted Time:
2017-07-19 16:06:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1496671 Calithera Biosciences Inc. CALA Pharmaceutical Preparations (2834) 272366329
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1555744 Stephanie Wong C/O Calithera Biosciences, Inc.
343 Oyster Point Blvd. #200
South San Francisco CA 94080
Vp, Finance And Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-07-17 3,552 $18.41 10,550 No 4 S Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,500 Direct
Footnotes
  1. Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan adopted on June 16, 2017.
  2. Shares were held by the Wong Family Trust, of which the reporting person is a trustee.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.90 to $18.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  4. Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on June 9, 2017.